跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Docetaxel Pfizer 10mg/mL (20mg/2mL) Concentrate for Solution for Infusion - TGA Drug Approval Details
Approvals
/
TGA
/
Docetaxel Pfizer 10mg/mL (20mg/2mL) Concentrate for Solution for Infusion
Approved
STANDARD
Docetaxel Pfizer 10mg/mL (20mg/2mL) Concentrate for Solution for Infusion
Pfizer (Perth) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7fbeed72807faf9c
Company
Pfizer (Perth) Pty Ltd
Type
Standard
Approval Details
Approval Id
7fbeed72807faf9c
Product Name
Docetaxel Pfizer 10mg/mL (20mg/2mL) Concentrate for Solution for Infusion
Artg Id
206273
Artg Name
Docetaxel Pfizer 10mg/mL (20mg/2mL) Concentrate for Solution for Infusion
Sponsor
Pfizer (Perth) Pty Ltd
Company Detail Path
/organization/pfizer-perth-pty-ltd
Artg Date
2013-02-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7fbeed72807faf9c
Type
Standard
Back to TGA Approvals
